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Nanopore sequencing for rapid 
diagnostics of salmonid RNA 
viruses
Michael D. Gallagher1,5, Iveta Matejusova2, Lien Nguyen1, Neil M. Ruane3, Knut Falk4 & 
Daniel J. Macqueen1,5
Analysis of pathogen genome variation is essential for informing disease management and control 
measures in farmed animals. For farmed fish, the standard approach is to use PCR and Sanger 
sequencing to study partial regions of pathogen genomes, with second and third-generation 
sequencing tools yet to be widely applied. Here we demonstrate rapid and accurate sequencing of two 
disease-causing viruses affecting global salmonid aquaculture, salmonid alphavirus (SAV) and infectious 
salmon anaemia virus (ISAV), using third-generation nanopore sequencing on the MinION platform 
(Oxford Nanopore Technologies). Our approach complements PCR from infected material with MinION 
sequencing to recover genomic information that matches near perfectly to Sanger-verified references. 
We use this method to present the first SAV subtype-6 genome, which branches as the sister to all other 
SAV lineages in a genome-wide phylogenetic reconstruction. MinION sequencing offers an effective 
strategy for fast, genome-wide analysis of fish viruses, with major potential applications for diagnostics 
and robust investigations into the origins and spread of disease outbreaks.
Pathogen genome sequencing greatly enhances the study of viral disease evolution, phylogeography and epidemi-
ology1, including human epidemics such as Ebola2, HIV3, and influenza4,5. Second-generation sequencing plat-
forms (e.g. Illumina) are now used routinely for genome-wide monitoring and investigations of viral disease, and 
generate accurate short-read data at massive throughput6–8, typically requiring computationally-intensive analy-
sis pipelines. Third-generation platforms, including single-molecule real time (SMRT)9 and Oxford Nanopore10 
show high promise for genome-wide analysis of viruses11,12, and bring the additional benefit of longer sequencing 
reads offset by higher error rates. The MinION nanopore sequencer is a particularly promising technology for 
viral research and diagnostics, owing to several unique features (i.e. portability, low start-up costs, real-time data 
generation and straightforward application) that have, for example, allowed human pathogens to be rapidly char-
acterized in the field without high-power computing or major laboratory infrastructure13,14.
Aquaculture is the fastest growing food production sector15, yet its sustainability and expansion is threatened 
by infectious diseases. Among a list of concerning pathogens, several known viral disease agents cause major 
animal health and welfare issues, accompanied by massive financial losses through mortalities, slow growth, 
poor flesh quality, treatment interventions and control protocols (e.g. culling)16,17. Accurate diagnosis of viral 
diseases is an essential part of strategic planning to manage existing and limit future outbreaks, and is especially 
important considering the lack of fully-effective treatments and vaccines for most fish viral pathogens (e.g.18–20). 
Recommended diagnostic procedures of viral disease include demonstration of clinical pathology coupled to the 
presence of pathogen DNA/RNA, followed by culturing to establish the presence of viable pathogen21. Diagnostic 
sequencing of aquatic viruses is typically done by PCR and Sanger sequencing, which benefits from high accuracy 
and established protocols. However, such approaches are limited to relatively short sequences (i.e. up to 1500 bp 
when sequencing both directions) and cannot gain a genome-wide representation of viruses and their variants 
without non-routine effort. Second and third generation sequencing tools hold promise for the characterization 
of aquatic viruses (reviewed in22,23), including pathogens affecting global fish aquaculture, yet they are being 
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up-taken relatively slowly. The utility of such approaches have been demonstrated by the characterisation of novel 
pathogens such as Tilapia Lake Virus (TiLV) using Ion Torrent sequencing24, the discovery of Piscine Reovirus 
(PRV)25 and Piscine myocarditis virus (PMCV)26 with pyrosequencing, and the analysis of Cyprinid herpesvirus 
3 genomes using a target enrichment and Illumina sequencing approach to identify mixed genotype infections27. 
However, as far as we are aware, to date no published studies have successfully used MinION sequencing to study 
viral diseases impacting farmed fish.
In this study, we demonstrate rapid genome-wide sequencing of fish viral pathogens using nanopore sequenc-
ing on the MinION platform. We focussed on two disease agents affecting farmed Atlantic salmon (Salmo 
salar L.), salmonid alphavirus (SAV) and infectious salmon anaemia virus (ISAV). SAV is a single-strand 
positive-strand RNA virus (Family Togaviridae) and the causative agent of pancreas disease, prevalent across 
European salmon aquaculture, with six SAV subtypes (SAV1-6) established28. All SAV sequences published to 
date have been generated using the Sanger method, including full genomes for SAV1-329–33, and partial genomic 
regions primarily encoding a glycoprotein (E2) or a non-structural protein (NsP3) (neither representing known 
virulence markers), for samples representing all six subtypes (e.g.28,34). ISAV is a highly pathogenic, segmented, 
negative-strand RNA virus (Family Orthomyxoviridae) often resulting in high mortality rates35,36, with con-
tainment and culling being the only effective mitigation strategy37. ISAV genomes have been Sanger-sequenced 
from several ‘genogroups’38–43, while segments 5 and 6, which contain known virulence markers and respectively 
encode the fusion and hemagglutinin surface proteins, are routinely used for Sanger genotyping, but have also 
been characterized using Illumina sequencing44. Overall, in common with other fish viruses, there is a lack of 
genome-wide data for SAV and ISAV, limiting power to define virulence markers and understand the evolu-
tion of different viral lineages. This study linked MinION sequencing to standard PCR enrichment to accurately 
sequence and genotype both SAV and ISAV. In addition to reporting the first full genome sequence for SAV6, we 
discuss the potentially transformative applications of MinION sequencing in diagnostics and molecular epide-
miology of viruses impacting aquaculture.
Results and Discussion
SAV genome-wide sequencing. Using primers matching conserved regions of the SAV genome (Table 1), 
three overlapping PCR amplicons (approx. 4 kb each; Supplementary Fig. 1) were obtained from two samples 
known to represent SAV1 (SCO/4640/08) and SAV6 (F1045-96) (Table 2) and sequenced on separate MinION 
flow cells (R9.4) for 2–3 hours (sequencing details provided in Supplementary Table 1). Over 98% of each SAV 
genome was recovered with 90 bp missing at the 5′ and 30 bp at the 3′ region of the genome due to the location 
of the highly conserved primer binding sites. The average read length from both sequencing runs was ~3800 bp 
per amplicon, indicating limited DNA shearing during the library preparation. The sequencing of sample 
Virus Primer Name Primer sequence/5′ - 3′
Amplicon 
Length
SAV
Structural
CMAACTCAGCCTAYCGCCAG
3914
GCACTTCTTCACCACGCAG
Non-structural/a
AGACTGCGTTTCCAGGGTT
4078
ATGTCGGTCAGTTGAGGGC
Non-structural/b
AGTGGGAYWCTAAGCCGAGAGG
4488
TACACGGGGAAGGTGCTCTG
ISAV
Fusion
ATGGCTTTTCTAACAATTTTAGTCT
1301
AGCACCACCAACACAACTACA
Hemagglutinin
GGCACGATTCATAATTTTATTCCT
1146*
GAACAGAGCAATCCCAAAACCT
Table 1. PCR primers used in the study. Primers were designed in conserved regions of the genome to be 
applicable for a wide range of strains. *The amplicon length of an isolate with a full HPR region/HPR0.
Virus Isolate
Year of 
Isolation Country of Isolation Cell Line Subtype
SAV
SCO/4640/08 2008 United Kingdom CHSE SAV1
F1045-96 1996 Ireland BF2/EPC SAV6
ISAV
SCO/4750/09 2009 United Kingdom NA EU-G1
CA/NB04-85-1/04 2004 Canada NA EU-NA
CA/NB7178/08 2008 Canada NA EU-NA
CA/F679/99 1999 Canada NA EU-NA
NO/Sotra/B797/92 1992 Norway NA EU-G3
SCO/4661/08 2008 United Kingdom NA EU-G1
NO/Glessvær/2/90 1990 Norway NA EU-G2
Table 2. Details of isolates used for MinION sequencing.
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SCO/4640/08 was stopped after 3-hours producing over 400 Mb of ‘pass’ reads (Q-score ≥ 7), resulting in almost 
40,000x coverage throughout the genome (Table 3). By mapping against the Sanger sequenced SAV1 reference 
sequence for SCO/4640/0832
As the above approach led to an accurate representation of a verified SAV genome sequence, we can be con-
fident in its application to discovering entirely novel variation. For this reason, we decided to sequence SAV6 
(sample F1045-96), which has only been identified once, as partial E2 and NsP3 sequences, from a single Irish 
sample28, and is highly distinct from all other subtypes. After two hours of sequencing, a genome-wide average of 
21,000x coverage was achieved. The SAV6 genome consensus showed 100% similarity to Sanger-sequenced NsP3 
(EF675499) and E2 (EF675547) gene sequences. Table 4 shows consistent genome-wide pairwise similarities 
contrasting the genome of SAV6 to the other SAV sub-types at both nucleotide and amino acid level (88.6–89.2% 
and 93.8–94.6% respectively). Variability among SAV subtypes differed based on the gene of interest and the 
greatest variability was seen in the NsP3 gene (82.0–83.8% and 87.7–89.8% nucleotide/amino acid similarity). In 
conclusion, these data gained by MinION sequencing confirm for the first time using genome-wide evidence that 
SAV6 represents a highly-divergent SAV subtype.
Genome-wide SAV phylogeny. Previous studies have failed to establish the position of SAV6 within the 
SAV phylogeny based on E2 and NsP3 sequences (e.g.28,34). We performed genome-wide phylogenetic reconstruc-
tions incorporating the new SAV6 genome gained by MinION sequencing, along with 17 SAV genomes available 
in NCBI, and 5 new (i.e. previously unpublished) Sanger-sequenced genomes for SAV2, 4 and 5 (isolate details 
in Supplementary Table 2). We used two probabilistic methods, the first a Bayesian approach incorporating a 
relaxed clock model45 allowing estimation of the tree root46 and the second an unrooted maximum-likelihood 
(ML) approach (Fig. 1). The root of the SAV phylogeny was estimated with high confidence (posterior probabil-
ity: 0.97), and split SAV6 from all other SAV sub-types. Branching of other subtypes was maximally supported 
(posterior probability: 1.0; ML bootstrap values > 95%), with SAV3 and 2 forming a monophyletic group separate 
from a clade containing SAV1, 4 and 5 (Fig. 1). The basal phylogenetic position of SAV6 highlights particular 
importance for the new MinION genome sequence in future investigations of the evolution and phylogeography 
of the major SAV lineages.
ISAV segment 5 and 6 sequencing. To test MinION sequencing on a distinct fish virus, we focused our 
efforts on ISAV, which exists in eight genomic segments (length: 740–2169 bp). This inherent aspect of the virus 
Virus Isolate
No. of Reads 
sequenced
No. of 
reads 
mapped
% reads 
mapped
Average 
Genome 
Coverage ISAV HPR
SAV
F1045-96 73,574 66,705 91 21,306 —
SCO/4640/08 112,805 93,998 83 39,012 —
ISAV
SCO/4750/09 25,009 24,797 99 9,609 HPR35
CA/NB04-85-1/04 11,816 11,201 95 9,932 Uncharacterised
CA/NB7178/08 20,136 19,672 98 4,464 Uncharacterised
CA/F679/99 18,650 18,308 98 4,593 Uncharacterised
NO/Sotra/B797/92 13,410 13,192 98 4,950 HPR1
SCO/4661/08 23,793 23,584 99 9,710 HPR35
NO/Glessvær/2/90 39,343 38,463 98 19,232 HPR2
Table 3. MinION sequencing details after basecalling and quality control. ISAV HPR classification based on 
established genotypes outlined in Nylund et al. 2003.
Gene
SAV6/SAV1 
(NUC/AA)
SAV6/SAV2 
(NUC/AA)
SAV6/SAV3 
(NUC/AA)
SAV6/SAV4 
(NUC/AA)
SAV6/SAV5 
(NUC/AA)
NSP1 91.8/94.7 91.6/95.5 92.7/95.7 91.8/95.3 92.3/95.7
NSP2 89.9/95.6 89.8/95.9 89.8/96.7 89.5/95.8 89.8/96.2
NSP3 83.8/88.9 82.8/88.2 82.0/87.7 83.2/89.4 83.8/89.8
NSP4 87.9/95.6 89.3/96.1 88.5/96.4 87.5/95.2 88.3/96.2
CP 90.2/91.8 89.2/90.8 90.3/93.3 90.7/93.3 91.5/92.9
E3 88.7/93.0 85.4/93.0 86.9/94.4 83.6/88.7 85.9/93.0
E2 87.8/92.7 87.1/91.8 87.2/92.9 85.5/92.5 87.0/93.4
6K 91.2/95.6 89.7/94.1 93.1/97.1 91.7/97.1 91.2/95.6
E1 91.4/96.7 90.5/96.2 90.6/95.6 90.9/96.9 91.9/97.1
Genome 89.2/93.9 88.6/93.8 88.7/94.3 88.3/94.2 89.0/94.6
Table 4. Pairwise similarities between SAV6 and reference genomes for SAV1-5. Reference sequences as 
follows: SAV1/AJ316244, SAV 2/AJ316246 and SAV3/KC122925. References for SAV4 (SAV 04-44) and SAV5 
(SAV SCO10-684) were generated in this study.
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limits one of the main benefits of MinION sequencing: its capacity to generate genome-wide representation of a 
virus with a small number of overlapping PCR amplicons, as done successfully for SAV. We instead focused on 
ISAV segments 5 and 6, which are widely studied and known to contain ISAV virulence markers, this time testing 
a barcoding approach to sequence multiple samples on a single MinION flow cell. PCR amplicons (primers in 
Table 1) amplifying 97% of segment 5 and 93% of segment 6 including both virulence markers, were obtained 
from seven ISAV isolates (Table 2) and pooled in equimolar amounts for sequencing after barcoding. After 
3 hours, approx. 9,000x mean coverage was achieved per sample. Only one of the isolates used in this study has a 
reference Sanger sequence (NO/Glessvær/2/90); basecalling accuracy was estimated for segments 5 and 6 of this 
isolate and 100% similarity was observed.
ISAV segment 6 contains a highly polymorphic region (HPR) at the 3′ end of the gene which is a known 
virulence marker. The putatively non-pathogenic ISAV, called HPR0, is characterized by a full length of the HPR 
comprising 35 amino acids and all pathogenic ISAV strains to date (called HPR-deleted) contain a deletion in the 
HPR region of varying length47. While none of the isolates used in this study were HPR0, the HPR of all the ISAV 
isolates used in this study were successfully classified with several different deletions being identified includ-
ing three samples CA/NB04-85-1/04, CA/NB7178/08, CA/F679/99 which have a deletion previously found only 
once before and not yet fully characterised48 (Table 3). In addition, the consensus sequences for each segment 5 
captured another proposed virulence marker, the substitution Q266L39,49,50, with all but one isolate (CA/NB04-85-
1/04) possessing the L variant. CA/NB04-85-1/04 instead encodes for a proline at this position which while unu-
sual, is also present in a Canadian isolate from the EU/NA genogroup (EF432567)51. These data thus demonstrate 
that MinION sequencing effectively recaptures sequence-level virulence markers.
Optimal sequence coverage. Future studies would benefit from establishing the necessary coverage 
required to determine confident consensus sequences using MinION. Thus, we randomly sampled MinION 
reads mapping to segments 5 and 6 of one ISAV sample (NO/Glessvær/2/90) and the SAV1 genome (sample: 
SCO/4640/08) at different coverages to establish the impact on consensus sequence accuracy (Fig. 2A–C). 50x 
and 500x coverage of either ISAV segment achieved a consensus sequence >99% and 100% identical to the Sanger 
reference, respectively (Fig. 2A,B). For SAV1, just 20x coverage led to 99% similarity with the Sanger reference, 
while 1,000x coverage led to 99.97% similarity (Fig. 2C). Thus, despite its high error rate (e.g.10), a highly-accurate 
consensus sequence can be generated with very modest MinION sequencing time.
Broader perspectives and comparisons with other platforms. Rapid sequencing of two 
structurally-distinct fish RNA viruses was achieved with high accuracy using MinION sequencing coupled with 
PCR. While the samples used were from cultured viruses, we have had equal success using the same proto-
cols and infected tissues with much lower virus titres (data not shown). The methods described were achieved 
within 24 hours lab-time, exploiting PCR primers matching conserved genomic regions, which allowed a highly 
divergent viral genome (SAV6) to be sequenced with little prior knowledge of sequence variation. Combining 
Figure 1. Genome-wide Bayesian phylogeny for SAV lineages including the SAV6 sequence generated by 
MinION sequencing (shown in red). The data represents an 11,638 bp nucleotide alignment and the analysis 
was done using the best-fitting nucleotide substitution model (GTR) and a relaxed molecular clock model. 
Branch posterior probability support is shown with comparable ML bootstrap support given in parentheses. 
Branch lengths are scaled in relative time as the relaxed clock model was uncalibrated. Root posterior 
probability (RPP) estimated by RootAnnotator46 is shown in red font.
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such turn-around and ease of application with the accuracy gained from moderate sequencing coverage opens 
the doorway to routine high-confidence viral genotyping at shallow phylogenetic scales, sufficient for robust 
diagnostics supporting disease management and regulatory decisions. Elsewhere, it has also been shown that 
Figure 2. Impact of MinION read coverage on accuracy of consensus sequence generation. ‘% identity’ is 
shown between reference Sanger sequences and consensus sequences generated from randomly sampling 
MinION reads at multiple sequence coverages for: (A) Segment 5 of ISAV NO/Glessvær/2/90; (B) Segment 6 of 
ISAV NO/Glessvær/2/90; (C) SAV1 genome (sample SCO/4640/08).
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MinION sequencing can be used to recover viral RNA genomes from infected samples without prior PCR enrich-
ment, which has advantages in the field52 and can also potentially identify viruses beyond the target pathogen. 
The ease of generating genome-wide sequencing data for non-segmented viruses such as SAV has revolution-
ary potential for diversifying the relatively restricted current repertoire of publicly-available fish virus genomes, 
bringing benefits for fundamental research and disease management. However, it is important to acknowledge 
that our approach is best-suited to generating consensus viral genome sequences, and less useful for identifying 
population variation within samples, which is well-established for RNA viruses53–58, as the PCR enrichment may 
introduce biases toward particular variants, and the high sequencing error rate of MinION reduces power to call 
low frequency variants de novo.
Future efforts should also aim to reduce the cost of genome-wide sequencing using multiplexing to exploit the 
high coverage possible on a single MinION flow cell. We estimate that the single SAV genomes (~12 kb) generated 
in our study cost approx. £850 each, including all consumables and an entire flow cell; however, multiplexing 
using 96 samples and the same approach would reduce this cost to approx. £50–60 per sample. By comparison, 
it would not be possible to perform a direct-equivalent Sanger sequencing approach, as the amplicon length 
exceeds the possible length of sequenced reads. Assuming an SAV genome was tiled across 7 PCR amplicons 
(e.g.32) and sequenced directly using Sanger with no cloning step (which would add further costs), we estimate a 
cost of approx. £100 per SAV consensus genome, including all reagents and bi-directional sequencing. In addition 
to a per-genome saving, the MinION approach is more convenient and time-efficient when a large number of 
genomes need to be sequenced, being done in-house in a single sequencing run with fewer amplicons, avoiding 
the need for cloning and the use of an external Sanger provider. It is more challenging to directly compare costs 
of our MinION strategy with alternative high-throughput approaches, as there are many platforms and variations 
in library preparation strategy, and this would also be affected by the extent of sub-contracting to an external 
provider. However, we estimate that the costs of generating complete SAV genomes using Illumina at the same 
scale (i.e. 96 samples), assuming the same amplicon strategy followed by in-house library preparation/indexing 
(Nextera XT DNA kit) and sequencing on the MiSeq platform by an external provider to be approx. £50–65 (i.e. 
very comparable). While Illumina brings advantages in terms of data accuracy, e.g. giving more scope for detect-
ing viral population variation, the MinION avoids use of an external provider, which typically leads to a lag of 
weeks to months for delivery. Overall, our MinION approach has some cost and/or time advantages when com-
pared to Sanger and Illumina approaches if the aim is to recover a consensus SAV genome with high accuracy, and 
future work is needed to develop this approach for robust analysis of viral population variation.
In conclusion, once low cost MinION sequencing of fish viral genomes is achieved, considering the unique 
portability of the sequencer alongside the modest computational power needed to analyse the resultant data, it 
seems reasonable to anticipate in-field diagnostic applications in the near future, including the monitoring of viral 
genotypes and subtypes directly on fish farms and in the field.
Materials and Methods
Sample preparation and PCR. Total RNA was extracted from SAV and ISAV samples (Table 2) using 
a phenol-chloroform extraction method, except for the SAV6 sample, which was extracted using a Viral RNA 
Isolation kit (Qiagen). cDNA was synthesised using Protoscript II (New England Biolabs) reverse transcriptase 
and a mix of random hexamer and oligo dT (dT23VN) primers (New England Biolabs) as per the manufacturers’ 
instructions. First-strand cDNA was used as template for long-range PCR reactions.
To amplify the SAV1/6 genomes, degenerate PCR primers targeting three ~4 kb overlapping amplicons were 
designed in regions of the genome conserved in the five subtypes where sequence data is available (Table 1). PCR 
was conducted using LongAmp polymerase (New England Biolabs) with cycling conditions as follows: 30 s at 
94 °C, followed by 35 cycles of 15 s at 94 °C, 1 min at 56 °C and 3 min 50 s at 65 °C, with a final extension for 10 min 
at 65 °C. ISAV segments 5 and 6 were amplified using the same approach and primers designed to conserved 5′ 
and 3′ regions of segment 5/6 (Table 2) under the same conditions, except that the PCR extension time was 2 min 
30 s. PCR products were visualised on a 1% agarose gel, purified using QIAquick Gel Extraction Kit (Qiagen) and 
stored at −80 °C until sequencing.
Sanger sequencing of novel SAV genomes. Seven overlapping PCRs were performed in triplicates for 
five SAV isolates (Supplementary Table 2) according to the methods published by Matejusova et al.32. The com-
plete SAV genomes were generated by Sanger sequencing, assembled using Sequencher v5.4.6 and used in the 
phylogenetic analysis presented in Fig. 1.
Preparation of SAV Library and sequencing. 1000 ng of equimolar pooled amplicon from each SAV 
isolate was the input to a library generated with the Ligation Sequencing Kit 1D SQK-LSK108 (Oxford Nanopore 
Technologies). Before ligating sequencing adaptors, DNA was end-repaired using the NEBNext Ultra II End 
Repair/dA Tailing kit (New England Biolabs), purified using AMPure XP beads (Beckman Coulter) in a ratio of 
1:1 volume of beads per sample and eluted in 30 µl of nuclease-free water (Sigma). Sequencing adapters (AMX1D) 
(ONT) were ligated to the DNA using Blunt/TA Ligation Master Mix (New England Biolabs) by incubation at 
room temperature for 10 min. The adapter-ligated DNA library was purified with AMPure XP beads in a ratio of 
1:2.5 volume of beads per sample, followed by a wash with Adapter Bead Binding buffer (ABB) (ONT) and elution 
in 15 µl nuclease-free water. DNA concentrations were determined between each step using a Qubit fluorimeter 
(Fisher Thermo). Each cleaned library was loaded onto a separate MinION Flow Cell Mk1 R9.4 (ONT) and 
run via MinKNOW software (without real-time basecalling) for 2 and 3 hours for SAV6 (F1045-96) and SAV1 
(SCO/4640/08) respectively.
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Preparation of ISAV Library and Sequencing. The ISAV library was prepared using the Ligation 
Sequencing Kit 1D SQK-LSK108 and a Native Barcoding Kit EXP-NBD103 (Oxford Nanopore Technologies). 
Segments 5 and 6 from the same virus isolate were pooled in equimolar amounts and 300 ng of each isolate 
end-repaired using the NEBNext Ultra II End Repair/dA Tailing kit. DNA was purified using AMPure XP beads 
in a ratio of 1:1 volume of beads per sample and eluted in 30 µl nuclease-free water. Native barcodes were ligated 
to 200 ng of end-repaired DNA using Blunt/TA Ligation Master Mix. The barcoded DNA was purified using 
AMPure XP beads in a ratio of 1:1 volume of beads to sample to remove excess barcodes and eluted in 26 µl 
nuclease-free water. The barcoded samples were pooled in equimolar amounts to a total of 200 ng library DNA 
(~0.2 pmol as per Oxford Nanopore Technologies instructions). Barcode adapter mix (BAM) (ONT) was ligated 
to the library DNA using NEBNext Quick Ligation Reaction Buffer and Quick T4 DNA Ligase (New England 
Biolabs), and incubated at room temperature for 10 min. Library DNA was purified using AMPure XP beads in 
a ratio of 1:2.5 volume of beads per sample and subsequently washed with Adapter Bead Binding buffer (ABB) 
before elution in 15 µl nuclease-free water. DNA concentrations were determined between each step as above. 
Libraries were loaded according to the native barcoding kit protocol (ONT) onto a MinION Flow Cell Mk1 R9.5., 
using a 3-hour sequencing run via MinKNOW without real-time basecalling.
Basecalling and consensus assembly. MinION data basecalling and demultiplexing for barcoded ISAV 
samples was performed using Albacore v.2.1.7 on Windows command line. Base-called FASTQ files were loaded 
into Geneious v.1059 for mapping and analysis. SAV1 (SCO/4640/08) sample reads were mapped to the SAV1 
Sanger-reference sequence32. SAV6 (F1045-96) sample reads were individually mapped to the partial gene E2 and 
NsP3 sequences of SAV628 and reference genomes for SAV132, SAV229, SAV333, SAV4 (generated in this study; 
isolate SAV 04-44) and SAV5 (generated in this study; isolate SCO10-684). In order to reconstruct the whole 
SAV6 genome, mapping was set at 5 iterations and a 65% consensus threshold. The 5 generated SAV consensus 
sequences were then manually inspected and any single base ambiguities resolved by parsimony, giving a final 
F1045-96 (SAV6) consensus sequence. For example, at position 2235, 4 out of 5 consensus sequences were the 
base G, whereas one consensus sequence was A: in this case, G was adopted for the final consensus. The ISAV 
samples were individually mapped to the previously sequenced segment 5 and 6 of the Scot157/08 isolate60 using 
the same parameters.
Reads for ISAV NO/Glessvær/2/90 segments 5 and 6, and SAV1 (SCO/4640/08) were subjected to ran-
dom subsampling to determine the depth of coverage necessary to generate an accurate consensus (i.e. Fig. 2). 
Subsampling was performed in Geneious v.10 using the ‘Randomly Sample Sequences’ workflow. Subsampled 
reads were realigned to the reference sequences using the same mapping methods as above and consensus 
sequences were generated from each alignment and compared to the reference Sanger sequence using pairwise 
alignment. Consensus sequences were aligned against all published genome sequences using MAFFT v.761 and 
manually inspected for errors in the mapping that disrupted the protein coding sequences in BioEdit software 
v.7.2.562. Sequence pairwise similarities were calculated using Geneious statistics of the MAFFT-aligned whole 
genome sequences.
Genome-wide SAV phylogenetic analyses. Multiple sequence alignment of 23 SAV genomes 
(Supplementary Table 2) was done using MAFFT v.7, generating an 11,638 bp alignment (provided in 
Supplementary Dataset 1), which was uploaded to the IQ-TREE server63 to determine the best-fitting nucleo-
tide substitution model (GTR) and generate a phylogenetic tree with support values gained from 1,000 Ultrafast 
Bootstrap iterations64. Bayesian phylogenetic analysis was done using the same dataset in BEAST265 employing 
a relaxed clock model45, a Coalescent Bayesian Skyline tree model66, the GTR substitution model and a Markov 
Chain Monte Carlo (MCMC) chain of 200 million generations. Tracer67 was used to assess MCMC convergence 
and estimate effective sample sizes for all sampled parameters (>2,000 in all cases). TreeAnnotator was used 
to remove the first 10% of sampled trees as burn-in and produce a Maximum Credibility Clade (MCC) tree. 
RootAnnotator46 was used to estimate posterior support for alternative root positions. MCC trees were visualized 
using FigTree (http://tree.bio.ed.ac.uk/software/figtree/).
Data Availability
MinION sequences for SAV isolates: SRA BioProject Accession SRP142226. SAV6 consensus genome: NCBI 
accession MH238448. MinION sequences for ISAV: SRA BioProject Accession SRP155694. ISAV segments 5 and 
6: NCBI accessions: MH708654-MH708667. Sanger-sequenced SAV genomes: NCBI accessions MH341514 and 
MH708650-MH708653.
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